These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 13458924)

  • 21. I-European research, the cradle of the discovery of the antidiabetic hormone: the pioneer roles and the relevance of Oskar Minkowski and Eugène Gley.
    de Leiva-Hidalgo A; de Leiva-Pérez A
    Acta Diabetol; 2022 Dec; 59(12):1635-1651. PubMed ID: 36239804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated somatostatin in pancreatic islets of adrenalectomized dogs.
    Rastogi KS; Efendic S; Lickley L; Kovacevic N; Vranic M
    Endocrinology; 1987 Feb; 120(2):544-8. PubMed ID: 2879722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omeprazole improves the anti-obesity and antidiabetic effects of exendin-4 in db/db mice (-4 db/db)*.
    Patel V; Joharapurkar A; Gandhi T; Patel K; Dhanesha N; Kshirsagar S; Dhote V; Detroja J; Bahekar R; Jain M
    J Diabetes; 2013 Jun; 5(2):163-71. PubMed ID: 22830490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [RENAL ACTION OF AN EXTRACT OF DE-INSULINIZED PANCREAS IN THE DOG].
    DEWONCK G; UME P; BACQ ZM; BARAC G
    C R Seances Soc Biol Fil; 1963 Aug; 157():909-12. PubMed ID: 14081764
    [No Abstract]   [Full Text] [Related]  

  • 25. Glucagon, the hyperglycemic agent in pancreatic extracts; a possible factor in certain types of diabetes.
    PINCUS IJ; RUTMAN JZ
    AMA Arch Intern Med; 1953 Nov; 92(5):666-77. PubMed ID: 13091483
    [No Abstract]   [Full Text] [Related]  

  • 26. Potential endocrine effects of hypothalamic peptide "neurotensin" on pancreas in dogs.
    Kawanishi K; Goto A; Ishida T; Kawamura K; Nishina Y; Machida S; Yamamoto S; Ofuji T
    Acta Med Okayama; 1978 Aug; 32(4):301-8. PubMed ID: 153091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of acute & prolonged BZ 55 treatment in the normal dog].
    CHRISTOPHE J; CONARD V
    Ann Endocrinol (Paris); 1957; 18(6):1046-56. PubMed ID: 13521430
    [No Abstract]   [Full Text] [Related]  

  • 28. Stimulatory effect of chelating agents and mesoxalate on the in vivo release of insulin in the pancreas of the dog. The possible role of amino acids.
    Ninomiya R; Miura Y; Kosaka K; Nakao K; Okinaka S
    Diabetes; 1966 Jan; 15(1):44-50. PubMed ID: 5907149
    [No Abstract]   [Full Text] [Related]  

  • 29. Insulin, proinsulin, glucagon and gastrin in pancreatic tumors and in plasma of patients with organic hyperinsulinism.
    Hayashi M; Floyd JC; Pek S; Fajans SS
    J Clin Endocrinol Metab; 1977 Apr; 44(4):681-94. PubMed ID: 14970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of pancreatic glucagon upon secretion of extrapancreatic glucagon in dogs.
    Ohneda A; Kobayashi T; Nihei J
    Horm Metab Res; 1985 Jul; 17(7):377. PubMed ID: 3897011
    [No Abstract]   [Full Text] [Related]  

  • 31. A-Cell and gut glucagon in normal and depancreatized dogs. Inhibition by somatostatin and insulin.
    Matsuyama T; Wider MD; Tanaka R; Shima K; Tarui S; Nishikawa M; Foà PP
    Diabete Metab; 1979 Jun; 5(2):141-7. PubMed ID: 478084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Endocrine pancreas and antidiabetics by oral route].
    VON HOLT C; VON HOLT L
    Ann Endocrinol (Paris); 1957; 18(2):171-3. PubMed ID: 13458915
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of hypoglycemia induced by agents other than exogenous insulin on duodenal motility in dogs under morphine-chloralose anesthesia: I. The arylsulfonylureas.
    BUNAG RD; RIGOR BM; TAN-GATUE LG; REOTUTAR WR; GUEVARA R
    J Philipp Med Assoc; 1959 Oct; 35():656-62. PubMed ID: 13805904
    [No Abstract]   [Full Text] [Related]  

  • 34. The isolation of insulin from a single cat pancreas.
    DAVOREN PR
    Biochim Biophys Acta; 1962 Sep; 63():150-3. PubMed ID: 14025543
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of pancreas extract on depancreatized dogs. Ernest L. Scott's thesis of 1911.
    Richards DW
    Perspect Biol Med; 1966; 10(1):84-95. PubMed ID: 6002670
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolic effects of continued administration of sulfonylurea derivatives in selected diabetic subjects: interrelations with glucagon.
    IZZO JL
    Ann N Y Acad Sci; 1959 Mar; 74(3):582-602. PubMed ID: 13637597
    [No Abstract]   [Full Text] [Related]  

  • 37. [Physiological and toxicological study of various hypoglycemic substances on normal and depancreatized dogs].
    SCHAMBYE P
    Ann Endocrinol (Paris); 1957; 18(2):174-83. PubMed ID: 13458916
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effects of prolonged ingestion of BZ-55 in low dose in the rat].
    LEDERER J; DE MEYER R
    Ann Endocrinol (Paris); 1957; 18(2):252-7. PubMed ID: 13458923
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effects of RP-2254 and BZ-55 on certain aspects of glucide metabolism; experimental research in normal, cortisone-treated or alloxanized rat].
    CONARD V; CHRISTOPHE J; BELLENS R; DE MEUTTER R; BASTENIE PA
    Ann Endocrinol (Paris); 1957; 18(2):246-51. PubMed ID: 13458922
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative study of several hypoglycemic sulfamides in alloxanized dogs].
    MARCO V; ANTON V
    Rev Esp Fisiol; 1959 Sep; 15():119-22. PubMed ID: 14420929
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.